137 related articles for article (PubMed ID: 27145281)
21. Flow Cytometric Assessment of CD26-Positive Leukemic Stem Cells: A Rapid and Valuable Tool in the Diagnosis and Follow-Up of Chronic Myeloid Leukemia.
Kana S; John S; Basu D; Kar R; Nachiappa Ganesh R; Dubashi B
Cureus; 2024 Mar; 16(3):e56944. PubMed ID: 38665755
[TBL] [Abstract][Full Text] [Related]
22. CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1.
Wang Z; Chen CC; Chen W
Stem Cells; 2015 Dec; 33(12):3437-51. PubMed ID: 26466808
[TBL] [Abstract][Full Text] [Related]
23. CML Mouse Model Generated from Leukemia Stem Cells.
Hu Y
Methods Mol Biol; 2016; 1465():27-35. PubMed ID: 27581136
[TBL] [Abstract][Full Text] [Related]
24. Targeting Chronic Myeloid Leukemia Stem/Progenitor Cells Using Venetoclax-Loaded Immunoliposome.
Houshmand M; Garello F; Stefania R; Gaidano V; Cignetti A; Spinelli M; Fava C; Nikougoftar Zarif M; Galimberti S; Pungolino E; Annunziata M; Luciano L; Specchia G; Bocchia M; Binotto G; Bonifacio M; Martino B; Pregno P; Stagno F; Iurlo A; Russo S; Aime S; Circosta P; Saglio G
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804056
[TBL] [Abstract][Full Text] [Related]
25. CD26/DPP-4 in Chronic Myeloid Leukemia.
Sicuranza A; Raspadori D; Bocchia M
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205639
[TBL] [Abstract][Full Text] [Related]
26. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
Jin B; Wang C; Li J; Du X; Ding K; Pan J
Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973
[TBL] [Abstract][Full Text] [Related]
27. Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients.
Mustjoki S; Richter J; Barbany G; Ehrencrona H; Fioretos T; Gedde-Dahl T; Gjertsen BT; Hovland R; Hernesniemi S; Josefsen D; Koskenvesa P; Dybedal I; Markevärn B; Olofsson T; Olsson-Strömberg U; Rapakko K; Thunberg S; Stenke L; Simonsson B; Porkka K; Hjorth-Hansen H;
Leukemia; 2013 Jul; 27(7):1520-6. PubMed ID: 23328954
[TBL] [Abstract][Full Text] [Related]
28. Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinib.
Janssen JJ; Deenik W; Smolders KG; van Kuijk BJ; Pouwels W; Kelder A; Cornelissen JJ; Schuurhuis GJ; Ossenkoppele GJ
Leukemia; 2012 May; 26(5):977-84. PubMed ID: 22157734
[TBL] [Abstract][Full Text] [Related]
29. FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells.
Crescenzi B; Chase A; Starza RL; Beacci D; Rosti V; Gallì A; Specchia G; Martelli MF; Vandenberghe P; Cools J; Jones AV; Cross NC; Marynen P; Mecucci C
Leukemia; 2007 Mar; 21(3):397-402. PubMed ID: 17215855
[TBL] [Abstract][Full Text] [Related]
30. Leukemia stem cells: the root of chronic myeloid leukemia.
Zhou H; Xu R
Protein Cell; 2015 Jun; 6(6):403-12. PubMed ID: 25749979
[TBL] [Abstract][Full Text] [Related]
31. Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34
Dolinska M; Piccini A; Wong WM; Gelali E; Johansson AS; Klang J; Xiao P; Yektaei-Karin E; Strömberg UO; Mustjoki S; Stenke L; Ekblom M; Qian H
Biochem Biophys Res Commun; 2017 Aug; 490(2):378-384. PubMed ID: 28623130
[TBL] [Abstract][Full Text] [Related]
32. Selective and effective targeting of chronic myeloid leukemia stem cells by topoisomerase II inhibitor etoposide in combination with imatinib mesylate in vitro.
Liu MY; Wang WZ; Liao FF; Wu QQ; Lin XH; Chen YH; Cheng L; Jin XB; Zhu JY
Cell Biol Int; 2017 Jan; 41(1):16-23. PubMed ID: 27677634
[TBL] [Abstract][Full Text] [Related]
33. Induction of Chronic Myeloid Leukemia in Mice.
Zhang H; Li S
Methods Mol Biol; 2016; 1465():17-25. PubMed ID: 27581135
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells.
Zhang B; Li L; Ho Y; Li M; Marcucci G; Tong W; Bhatia R
J Clin Invest; 2016 Mar; 126(3):975-91. PubMed ID: 26878174
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E1 and Its Analog Misoprostol Inhibit Human CML Stem Cell Self-Renewal via EP4 Receptor Activation and Repression of AP-1.
Li F; He B; Ma X; Yu S; Bhave RR; Lentz SR; Tan K; Guzman ML; Zhao C; Xue HH
Cell Stem Cell; 2017 Sep; 21(3):359-373.e5. PubMed ID: 28844837
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists.
Zhao Y; Wu K; Wu Y; Melendez E; Smbatyan G; Massiello D; Kahn M
Curr Mol Pharmacol; 2018; 11(2):113-121. PubMed ID: 28933312
[TBL] [Abstract][Full Text] [Related]
37. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
Jin Y; Zhou J; Xu F; Jin B; Cui L; Wang Y; Du X; Li J; Li P; Ren R; Pan J
J Clin Invest; 2016 Oct; 126(10):3961-3980. PubMed ID: 27643437
[TBL] [Abstract][Full Text] [Related]
38. The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia.
Galimberti S; Grassi S; Baratè C; Guerrini F; Ciabatti E; Perutelli F; Ricci F; Del Genio G; Montali M; Barachini S; Giuliani C; Ferreri MI; Valetto A; Abruzzese E; Ippolito C; Iurlo A; Bocchia M; Sicuranza A; Martino B; Iovino L; Buda G; Salehzadeh S; Petrini M; Di Paolo A; Mattii L
Front Oncol; 2018; 8():555. PubMed ID: 30574454
[TBL] [Abstract][Full Text] [Related]
39. Peripheral blood quantitation of CD26 positive leukemic stem cells as a predictor of tyrosine kinase inhibitor response in chronic myeloid leukemia.
Chaudhary N; Rahman K; Gupta P; Gupta R; Sarkar MK; Singh MK; Chandra D; Kumar S; Kashyap R
Int J Lab Hematol; 2024 May; ():. PubMed ID: 38711332
[TBL] [Abstract][Full Text] [Related]
40. Do endothelial cells belong to the primitive stem leukemic clone in CML? Role of extracellular vesicles.
Ramos TL; Sánchez-Abarca LI; López-Ruano G; Muntión S; Preciado S; Hernández-Ruano M; Rosado B; de las Heras N; Chillón MC; Hernández-Hernández Á; González M; Sánchez-Guijo F; Del Cañizo C
Leuk Res; 2015 Aug; 39(8):921-4. PubMed ID: 26105049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
